1. Home
  2. BHB vs XERS Comparison

BHB vs XERS Comparison

Compare BHB & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHB
  • XERS
  • Stock Information
  • Founded
  • BHB 1887
  • XERS 2005
  • Country
  • BHB United States
  • XERS United States
  • Employees
  • BHB N/A
  • XERS N/A
  • Industry
  • BHB Major Banks
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHB Finance
  • XERS Health Care
  • Exchange
  • BHB Nasdaq
  • XERS Nasdaq
  • Market Cap
  • BHB 558.4M
  • XERS 509.9M
  • IPO Year
  • BHB 1997
  • XERS 2018
  • Fundamental
  • Price
  • BHB $34.15
  • XERS $3.36
  • Analyst Decision
  • BHB Hold
  • XERS Buy
  • Analyst Count
  • BHB 2
  • XERS 3
  • Target Price
  • BHB $33.50
  • XERS $4.87
  • AVG Volume (30 Days)
  • BHB 31.4K
  • XERS 1.6M
  • Earning Date
  • BHB 01-21-2025
  • XERS 11-08-2024
  • Dividend Yield
  • BHB 3.49%
  • XERS N/A
  • EPS Growth
  • BHB N/A
  • XERS N/A
  • EPS
  • BHB 2.78
  • XERS N/A
  • Revenue
  • BHB $148,706,000.00
  • XERS $187,361,000.00
  • Revenue This Year
  • BHB N/A
  • XERS $23.48
  • Revenue Next Year
  • BHB $3.78
  • XERS $18.69
  • P/E Ratio
  • BHB $12.37
  • XERS N/A
  • Revenue Growth
  • BHB N/A
  • XERS 22.72
  • 52 Week Low
  • BHB $23.26
  • XERS $1.69
  • 52 Week High
  • BHB $38.47
  • XERS $3.87
  • Technical
  • Relative Strength Index (RSI)
  • BHB 43.51
  • XERS 50.76
  • Support Level
  • BHB $33.65
  • XERS $3.26
  • Resistance Level
  • BHB $36.00
  • XERS $3.63
  • Average True Range (ATR)
  • BHB 0.95
  • XERS 0.17
  • MACD
  • BHB -0.29
  • XERS -0.02
  • Stochastic Oscillator
  • BHB 12.79
  • XERS 15.57

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.

Share on Social Networks: